Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia.
Hegde PS., Andrew G., Gui G., Ravindra N., Mukherjee D., Wong ZC., Auletta JJ., El Chaer F., Corner A., Devine SM., Jimenez Jimenez AM., De Lima MJG., Litzow MR., Kebriaei P., Saber W., Spellman SR., Zeger SL., Page KM., Dillon LW., Hourigan CS.